tm logo
LYSOSEEKER
Live/Registered
REGISTERED

on 13 Aug 2024

Last Applicant/ Owned by

20457 Hamburg

DE

Serial Number

79366202 filed on 19th Jan 2023

Registration Number

7470222 registered on 13th Aug 2024

in the Principal Register

Correspondent Address

Claudia W. Stangle

Claudia W. Stangle Leydig, Voit & Mayer Ltd.

Two Prudential Plaza

Chicago, IL 60601-6745

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

LYSOSEEKER

Scientific and technological research in the field of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, therapeutics, chemistry and biochemistry; Pharmaceutical products development; research and development of new products for others; pharmaceutical drug development services; scientific laboratory services; medical research laboratory services; laborato Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services, medical diagnostic testing services; medical and pharmaceutical consultancy; medical analysis services relating to the diagnosis and treatment of persons; laboratory analysis services relating to the diagnosis and treatment of persons in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases; medical examinations; medical screening; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases, monogenic diseases, cancer, neurology, immunology, cardiovascular disease, and metabolic diseases;medical analysis services relating to the treatment of patients for diagnosising and treating illnessnes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological research in the field of medicine, biotechnology, biology, biomedicine, pharmaceuticals, genetics, molecular sciences, therapeutics, chemistry and biochemistry; Pharmaceutical products development; research and development of new products for others; pharmaceutical drug development services; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; database services, namely, electronic storage of data in computer databases; design, engineering, research, development and testing services in the field of pharmaceuticals, biotechnology, biology, biomedicine, genetics, molecular sciences, therapeutics, chemistry and biochemistry for medical, scientific, and technological applications; preparation of scientific analysis and evaluations namely, testing of pharmaceuticals and pharmaceutical product evaluation; consultancy relating to research and development in the field of therapeutics; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; development of pharmaceutical preparations and medicines; medical laboratory services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79366202

Mark Type

No Service Mark

Attorney Docket Number

No 769951

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Nov 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13th Aug 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Aug 2024REGISTERED-PRINCIPAL REGISTER
28th May 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28th May 2024PUBLISHED FOR OPPOSITION
08th May 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18th Apr 2024APPROVED FOR PUB - PRINCIPAL REGISTER
18th Apr 2024EXAMINER'S AMENDMENT ENTERED
18th Apr 2024EXAMINERS AMENDMENT E-MAILED
18th Apr 2024EXAMINERS AMENDMENT -WRITTEN